CD8A and non-small cell lung carcinoma: Conversely, within the TIME of the non-response group of NSCLC patients, solely the alteration in CD8+ Tbys-dys [2 (0.3) vs. 0 (0.0), p = 0.017] density was statistically significant after NCIT (Figure 3; Supplementary Table 3).